2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections.
暂无分享,去创建一个
M. Otto | E. De Clercq | L. Naesens | J. Neyts | A. Bousseau | D. Schols | D. Daelemans | G. Andrei | B. Bodaghi | R. Snoeck | L. Lagneaux | D. Bron | C. Nemecek | C. Roy | S. Michelson